Articles and Blogs

On March 15, 2017, the U.S. District Court for the Western District of Pennsylvania provided the first federal court interpretation of the writing requirements affecting several regulatory exceptions in the federal physician self-referral statute (“Stark Law”) and its implementing regulations since the Centers for Medicare & Medicaid Services (“CMS”) provided sweeping revisions and clarifications... READ MORE

On March 27, 2017, the Office of Inspector General for the U.S. Department of Health and Human Services (“OIG”) issued a resource guide to assist health care organizations in assessing the effectiveness of their compliance programs (“Resource Guide”). OIG developed the Resource Guide in collaboration with 30 health care compliance professionals through a collaborative... READ MORE

This is the fifth article in a series on the 21st Century Cures Act (the “Cures Act”), which was signed into law on December 13, 2016. We will continue publishing a series of articles summarizing various components under the Cures Act. The articles in our series are located here. This article highlights the opportunities... READ MORE

American Health Care Act Pulled Just Before House Vote Despite a last minute lobbying effort by President Trump, the Republican leadership in the House pulled the American Health Care Act (“AHCA”) off the floor minutes before a vote was scheduled to take place when it became evident there weren’t enough votes for it to... READ MORE

READ MORE

Hall Render attorneys will play a crucial role in providing Indianapolis residents with essential legal guidance at the Indianapolis Bar Association’s upcoming Ask a Lawyer event on Tuesday, April 11. As pro bono volunteers, Patricia Connelly, Charise Frazier, Jon Bumgarner, John Bowen, Laura Sahm and Nick Johnston will staff one of several locations throughout the... READ MORE

On March 20, 2017, the Food and Drug Administration (“FDA”) published a notice in the Federal Register delaying the implementation of the final rule (“Final Rule”) regulating off-label drug promotion until March 19, 2018. The Final Rule was published in the Federal Register of January 9, 2017. The effective date was originally delayed until... READ MORE

On February 8, 2017, the U.S. District Court for the District of Columbia (the “Court”) blocked the proposed $54 billion merger between Anthem, Inc. (“Anthem”) and Cigna Corp. (“Cigna”). This ruling comes on the heels of the Court’s decision to block the other insurance mega-merger ($37 billion) between Aetna Inc. and Humana Inc. Anthem... READ MORE

READ MORE

On March 20, 2017, the Centers for Medicare & Medicaid Services (“CMS”) published an interim final rule (the “Interim Final Rule“) effectively postponing the start date of CMS’s new episode payment models (“EPMs”) and the Cardiac Rehabilitation Incentive Payment Model (“CR Incentive Model”) from July 1, 2017 until October 1, 2017. The Interim Final... READ MORE